Zelira Therapeutics Limited (OTCMKTS:ZLDAF) Short Interest Update

Zelira Therapeutics Limited (OTCMKTS:ZLDAF) saw a large drop in short interest in the month of November. As of November 15th, there was short interest totalling 100 shares, a drop of 50.0% from the October 31st total of 200 shares. Based on an average trading volume of 200 shares, the short-interest ratio is currently 0.5 days.

Zelira Therapeutics Stock Performance

ZLDAF stock opened at $0.45 on Friday. The firm has a 50 day moving average price of $0.48 and a 200-day moving average price of $0.43. Zelira Therapeutics has a 52-week low of $0.19 and a 52-week high of $0.69.

About Zelira Therapeutics

Zelira Therapeutics Limited, a bio-pharmaceutical company, engages in the research, development, and commercialization of cannabinoid-based medicines for the treatment of various medical conditions in Australia and the United States. The company offers formulations under the HOPE brand in Australia, Washington, Pennsylvania, and Louisiana, as well as develops Zenivol, a cannabinoid-based medicine for treatment of chronic insomnia.